[Form 4] PROLOGIS, INC. Insider Trading Activity
Rhea-AI Filing Summary
Prologis director Cristina G. Bita sold 1,000 shares of Prologis common stock on 09/03/2025 at $111 per share under a pre-established 10b5-1 trading plan. After the sale, she beneficially owned 9,829 shares. The Form 4 lists her address as c/o Prologis in San Francisco and indicates the filing was signed by an attorney-in-fact on 09/04/2025. The transaction is reported as a routine sale executed pursuant to a written plan intended to provide the affirmative defense of Rule 10b5-1, rather than an opportunistic or ad hoc trade.
Positive
- None.
Negative
- None.
Insights
TL;DR: A routine, pre-planned director sale of 1,000 shares under a 10b5-1 plan; limited immediate market impact.
The sale of 1,000 shares at $111 reduces the director's holdings to 9,829 shares, representing a modest personal liquidity event relative to institutional free float. Because the trade was executed under a 10b5-1 plan dated August 1, 2025, it signals pre-commitment and reduces concerns about material non-public information driving the timing. The filing is procedural and contains no disclosures of company operational or financial changes.
TL;DR: Insider sale appears compliant and documented; governance controls (10b5-1 plan) were used.
The Form 4 shows the director used a documented 10b5-1 plan, which is a standard governance tool to mitigate insider trading risk. The report was executed by an attorney-in-fact and properly disclosed on Form 4, aligning with Section 16 reporting requirements. There are no indications of unusual or untimely insider activity in the filing itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,000 | $111.00 | $111K |
Footnotes (1)
- F1. THIS TRANSACTION WAS CONDUCTED IN CONNECTION WITH A 10B5-1 PLAN DATED AUGUST 1, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.